Basecamp Wealth Advisors’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.55K Buy
222
+2
+0.9% +$46 ﹤0.01% 1199
2026
Q1
$4.85K Sell
220
-2
-0.9% -$35 ﹤0.01% 1190
2025
Q4
$2.62K Buy
+222
New +$2.85K ﹤0.01% 1297

Other funds holding CC

Basecamp Wealth Advisors's CC Position: Q2 2026 in Review

Basecamp Wealth Advisors increased its Chemours (CC) stake by 0.91% in Q2 2026, buying an estimated $46 and bringing the position to 222 shares worth $4.55K. The position accounts for ﹤0.01% of the portfolio, ranked #1199.

Basecamp Wealth Advisors first reported a position in CC in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.85K in Q1 2026. 470 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Basecamp Wealth Advisors held 222 shares of Chemours worth $4.55K as of Q2 2026.
  • Basecamp Wealth Advisors bought 2 Chemours shares in Q2 2026, an estimated $46.
  • Chemours made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1199 holding.
  • Basecamp Wealth Advisors first reported a position in Chemours in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's Chemours position peaked at $4.85K in Q1 2026.
  • 470 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.